Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

You searched for:

Continued on back It’s common to have cancer along with another condition, such as diabetes. If you have both cancer and diabetes, you face more challenges than with either disease alone. The things you do to control your blood sugar may also help your cancer. When You Have Cancer and Diabetes Boost your treatment When you have cancer, your overall health may affect how …
Developing a Health Literacy and Clear Communications e-Course F R I D AY, A U G U S T 4 , 2 0 2 3 12:00 pm Registration Open, Networking Lunch / Resource Center 1:00 pm Welcome & Introductions Bobby Gor, MD, President, South Carolina Oncology Society 1:05 pm Exploring the Interplay Between Long COVID-19, Inflammation, Chronic Diseases, and Cancer Incidence Kashyap Patel, MD, Carolina …
Developing a Health Literacy and Clear Communications e-Course F R I D AY, A U G U S T 4 , 2 0 2 3 12:00 pm Registration Open, Networking Lunch/Resource Center 1:00 pm Welcome & Introductions Bobby Gor, MD, president, South Carolina Oncology Society 1:05 pm Exploring the Interplay Between Long COVID-19, Inflammation, Chronic Diseases, and Cancer Incidence Kashyap Patel, MD, Carolina …
Featured in Oncology Issues Genetic Cancer Screening and Testing in a Medically Underserved Community Genetic screening and testing are paving the way for improved patient care and outcomes on a broad scale that encompasses both cancer treatment and prevention. Access to this testing is key to identifying and thereby reducing disease burden, suffering, and cost. Being able to offer patients genetic …
TxSCO Leadership Day Febraury 29th - March 1st 2024 The Laura Hotel Houston TX Attendee Roster First Name Last Name Title Account Name Vincent Lecca Agios Gina Hoxie Associate Director of Coverage and Reimbursement, ASCO American Society of Clinical Oncology (ASCO) Dee Deatherage Account Specialist Amgen Oncology Justin Hudman Sr. Manager, State Government Affairs - Southwest …
PowerPoint Presentation NORTH CAROLINA LEGISLATIVE UPDATE Dana E. Simpson, J.D. Smith Anderson Law Firm August 3, 2024 OVERVIEW • Policy Overview • Political Overview 2 PRIOR AUTHORIZATION REFORM HB 649 – Ensure Timely and Clinically Sound Utilization Reviews o Sponsored by Rep. Kristin Baker, M.D. and Rep. Tim Reeder, M.D. o Sets time limits …
OCCM-Bibliography
Figure2_VulnerableEldersSurvey_VES13.indd Patient Name: ____________________________________________________ Date: _____________________________ Patient ID: ________________________________________________________ In general, compared to other people your age, would you say that your health is: Vulnerable Elders Survey-13 (VES–13) How much difficult, on average, do you …
Slide 1 Impact of antibiotics on residual cancer burden and pathologic response rates during neoadjuvant Pembrolizumab in breast cancer Amit Kulkarni1, Patricia Jewett1, Anne Blaes1, Douglas Yee1 1Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN BACKGROUND • Achieving pathologic complete response (pCR) following neoadjuvant chemotherapy …
From: Association of Community Cancer Centers Subject: Join us for Transform Infusion Center Operations Virtual Summit, Dec 6 View in Browser | Forward to a Friend A sponsored message brought to you by the Association of Community Cancer Centers More than 600 infusion centers are leveraging AI, analytics, and automation to expand patient capacity and unburden staff. Discover how your peers …
Date(s) Event Location Venue Event Type Approx. Attendees Saturday, February 3, 2024 WAHO SABCS Milwaukee, WI Pfister DISPLAY 190 Thursday, February 15, 2024 TOPS Symposium Memphis TN Restaurant Iris Networking - Corporate Members only 30 Feb. 16-17, 2024 SCOS/NCOA Joint Conference Charlotte, NC Charlotte Westin DISPLAY 209 Tuesday, February 20, 2024 HSCO ASH Symposium …
PowerPoint Presentation Perspectives from CAR T Treaters and Referrers in an Evolving B-Cell Lymphoma Landscape Girish Kunapareddy, MD Hematologist/Oncologist Union Health Rita Assi, MD Assistant Professor of Medicine Indiana University Melvin and Bren Simon Comprehensive Cancer Center Daniel Wojenski, PharmD Medical Science Liaison, Cell Therapy Bristol Myers …
AZIM21BLNY4681_M3_CORE_5Y_Efficacy_LB_Digital_Con- 6-2-2021 1:22 PM ptaylor / ptaylor Client Code Client Live Overall Trim Bleed # of Colors US-52243 AstraZeneca - Imfinzi SCLC 21.5" x 8" 22" x 8.5" 22.25" x 8.75" 4/4 process Colors Cyan, Magenta, Yellow, Black, PMS 187 C Fonts Helvetica Neue LT Std (57 Condensed, 77 Bold Condensed, 47 Light Condensed, 67 Medium …
3/21/22, 3:34 PM Capitol Hill Day https://www.accc-cancer.org/home/attend/accc-48th-annual-meeting-cancer-center-business-summit/capitol-hill-day/Action/Preview 1/7   Home / Attend / ACCC 48th Annual Meeting & Cancer Center Business Summit / Capitol Hill Day Capitol Hill Day   As Congress continues to deliberate reforms to our healthcare system and decide how to move forward during …
ND13-Action
Chemotherapy refusal and subsequent survival in older women with high genomic risk, estrogen-receptor positive breast cancer Chemotherapy refusal and subsequent survival in older women with high genomic risk, estrogen-receptor positive breast cancer Background: Patients with estrogen receptor (ER)- positive breast cancer (BC) and high-risk 21-gene recurrence score (RS) benefit …
PowerPoint Presentation New Mexico Society of Clinical Oncology 2022 • Jeffrey N. Weitzel, M.D. • Professor, Latin American School of Oncology • VP Medical Affairs Hereditary Cancer, Natera Cancer Genetics: A Vision for Precision DISCLOSURE OF CONFLICTS OF INTEREST Jeffrey N. Weitzel, M.D. has the following financial relationships to disclose: • Employee, Natera • …
Your relationship with patients is critical to ensure they receive care they truly want. Pharmacist2Pharmacist helps pharmacy professionals provide accurate information and up-to-date care to patients with prescriptions for aid-in-dying medications. It can be difficult to discuss a patient’s terminal illness and death — and crucial for pharmacists to knowledgeably consult directly with patients …
CORP-US3817 EAP Journal Ad copy R7 copy • Benefits investigation • Financial assistance • Appeal Information• Eisai Assistance Program Hotline • Prior Authorization Information © 2022 Eisai Inc. All rights reserved. CORP-US3817 June 2022 At Eisai, everything we do is guided by a simple principle: patients and their families come first and we have a responsibility to …